Photo of Jefferson Van Drew
R United States House · District 2 · New Jersey On the 2026 ballot

Rep. Jefferson Van Drew

Compare
Total votes
2,837
all sessions
Attendance
99%
23 missed
Near the chamber average
With party
91%
of cast votes
Lower than 76% of chamber peers
Bipartisan score
5%
crosses aisle rarely
Higher than 75% of chamber peers
Sponsored
1,699
bills & resolutions
Higher than 82% of chamber peers
Committees
7
assignments
1,699 bills and resolutions

Sponsored bills

Total
1,699
Primary
140
Co-sponsor
1,559
This page
1,699
matching current filters
Co-sponsor HR 7306
In committee · Indiana House · Co-sponsor
Strategy to Secure Offshore Energy Act

Strategy to Secure Offshore Energy Act This bill modifies requirements for the National Outer Continental Shelf Oil and Gas Leasing Program, including by specifying that the program must be updated on a five-year basis and setting a minimum number of annual lease sales for the program.

In committee Mar 30, 2022 1 co-sponsor
Co-sponsor HR 7293
In committee · Indiana House · Co-sponsor
Energy Permitting Certainty Act

Energy Permitting Certainty Act This bill requires the Department of the Interior to process applications for permits to drill under a valid oil or gas lease even if there are any pending civil actions, provided that the civil actions do not directly affect or involve the application or underlying lease.

In committee Mar 30, 2022 1 co-sponsor
Co-sponsor HR 7298
In committee · Indiana House · Co-sponsor
Promoting Energy Independence and Transparency Act

Promoting Energy Independence and Transparency Act This bill requires the Department of the Interior to take certain actions related to parcels of land that have been nominated for future sales of onshore oil and gas leases and related drilling permits. Specifically, Interior must (1) report to Congress about the status of the parcels, (2) publish on its website information concerning expressions of interest in nominated parcels and drilling permits, and (3) issue certain pending applications for drilling permits within 30 days.

In committee Mar 30, 2022 1 co-sponsor
Co-sponsor HR 7292
In committee Mar 30, 2022 1 co-sponsor
Co-sponsor HR 7255
In committee · Indiana House · Co-sponsor
Garrett Lee Smith Memorial Reauthorization Act

Garrett Lee Smith Memorial Reauthorization Act This bill reauthorizes through FY2027 multiple suicide prevention programs and related activities with a particular focus on youth and young adults. Specifically, the bill reauthorizes grants for statewide or tribal youth suicide prevention and early intervention strategies and for mental health and substance use disorder services for college students, a working group tasked with developing a plan to carry out a public education campaign concerning access to and reducing stigma associated with mental health services at institutions of higher education, and a suicide prevention resource center that provides training and other resources regarding suicide prevention among all ages.

In committee Mar 29, 2022 1 co-sponsor
Co-sponsor HR 7249
In committee · Indiana House · Co-sponsor
Anna Westin Legacy Act of 2022

Anna Westin Legacy Act of 2022 This bill requires the Substance Abuse and Mental Health Services Administration to maintain the National Center of Excellence for Eating Disorders (NCEED). The bill specifies required activities for NCEED, including providing training for frontline health care providers and other professionals.

In committee Mar 29, 2022 1 co-sponsor
Co-sponsor HR 7121
In committee · Indiana House · Co-sponsor
Protecting our Pharmaceutical Supply Chain from China Act of 2022

Protecting o ur Pharmaceutical Supply Chain from China Act of 2022 This bill requires the federal government to maintain a registry of certain foreign-sourced drugs, prohibits federal health care programs from purchasing drugs containing ingredients manufactured in China, requires drugs to be labeled for country of origin, and offers domestic manufacturing facility tax incentives. The Food and Drug Administration shall maintain (1) a list of foreign-sourced drugs and active ingredients that are critical for consumer health and safety, and (2) another list identifying such drugs that are produced exclusively in China or use ingredients produced in China. The bill phases in a restriction on federal health care programs purchasing drugs with active ingredients manufactured in China. By January 1, 2024, such programs may not purchase a drug with any active ingredients from China. The Department of Health and Human Services may issue a waiver for an agency or program that is unable to meet this requirement, but no waiver may apply to drugs purchased in or after 2026. Each drug must have labeling listing the country of origin of each active ingredient, and a drug without this labeling shall be deemed misbranded. The bill allows 100% tax expensing for qualified pharmaceutical and medical device manufacturing property placed in service between 2020 and 2026.

In committee Mar 28, 2022 1 co-sponsor
Co-sponsor HR 7048
In committee · Indiana House · Co-sponsor
Protect Lifesaving Anesthesia Care for Veterans Act of 2022

Protect Lifesaving Anesthesia Care for Veterans Act of 2022 This bill prohibits the Department of Veterans Affairs (VA) from modifying its policy relating to anesthesia care in a manner that would provide any medical professional other than a physician anesthesiologist with full practice authority for the furnishment of anesthesia care to veterans under VA health care laws. The VA is also prohibited from finalizing, implementing, or enforcing the provisions relating to anesthesia care of the proposed rule titled Advanced Practice Registered Nurses (81 Fed. Reg. 33155), or any substantially similar rule.

In committee Mar 28, 2022 1 co-sponsor
Co-sponsor HJRES 79
In committee · Indiana House · Co-sponsor
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of the Treasury and the Centers for Medicare & Medicaid Services relating to "Patient Protection and Affordable Care Act; Updating Payment Parameters, Section 1332 Waiver Implementing Regulations, and Improving Health Insurance Markets for 2022 and Beyond".

This joint resolution nullifies the rule titled Patient Protection and Affordable Care Act; Updating Payment Parameters, Section 1332 Waiver Implementing Regulations, and Improving Health Insurance Markets for 2022 and Beyond , which was issued by the Centers for Medicare & Medicaid Services and the Department of the Treasury on September 27, 2021. The rule expands the open enrollment period for individual health coverage and rescinds the previous interpretation of certain requirements relating to Section 1332 waivers (also known as State Innovation Waivers or State Relief and Empowerment Waivers).

In committee Mar 25, 2022 1 co-sponsor
Showing 1,231 to 1,240 of 1,699 bills